Despite beating analysts' estimates during its latest quarter, Doximity (NYSE: DOCS) stock took another nosedive after results were released this week. As of this writing, shares of the healthcare networking technologist are down 43% so far in 2022.
However, Doximity is growing at a fast and steady rate and is highly profitable. Investors who like companies using technology to serve customers but who are rattled by the tech sell-off should spend some time getting to know Doximity. Here's why this emerging healthcare leader is worth a look right now.
Image source: Getty Images.
For further details see:
Tech Stock Sell-Off Got You Scared? Here's a Better Buy.